Navigation Links
Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus'
Date:1/20/2011

CARLSBAD, Calif., Jan. 20, 2011 /PRNewswire/ -- Aubrey Inc. – http://www.aubreyinc.com – announced that after a successful soft release and product evaluation phase of its second generation product, AWBAT® Plus, it is now in full production and currently available for purchase.  Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again.  "It is a wonderful feeling to hear from a renowned surgeon that 'AWBAT® Plus has the potential to take wound coverage to the next level' and that it 'provides not only an optimal milieu but also a stimulus to promote active wound healing.'"

AWBAT® Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®.  AWBAT® Plus, however, contains not only significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E and Immuno-10 (activated mixture of polysaccharides from Aloe).  It was determined by FDA to be a combination product consisting of device components as well as drugs.  In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production.  Human keratinocyte production was also enhanced by Immuno-10.  AWBAT® Plus is currently indicated for partial thickness burns, meshed autografts, and donor sites.

Woodroof stated: "We are very excited to have AWBAT® Plus now also available in our proprietary glove design.  Hand burns are common injuries and complex wounds to treat. The AWBAT® Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work."

Aubrey Inc. intends to seek clearance for use of AWBAT® Plus on chronic wounds this year.  Woodroof noted that in an investigator initiated evaluation of AWBAT® Plus on chronic wounds, the surgeon stated, "We have found AWBAT®-D Plus to be an effective alternative to Apligraf®, Dermagraft® and Integra® in preliminary observations of chronic wound management.  AWBAT®-D Plus can be used as an adjunct with NPWT."

About Aubrey Inc.

Dr. Aubrey Woodroof invented Biobrane® in 1978, an innovative product which revolutionized burn care.  In 2007, Woodroof came out of retirement to create the AWBAT® line as the next generation of advanced wound care technology.


'/>"/>
SOURCE Aubrey Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... and PUNE, India , January ... by Allied Market Research, titled, "Vital Signs Monitoring Devices Market ... Forecast, 2014-2022", projects that the global vital signs monitoring devices ... expected to reach $5,491 million by 2022, growing at a ... America was the leading regional market in global ...
(Date:1/16/2017)... Oregon and PUNE, India , January 16, 2017 ... Research, titled, "Antioxidants Market by Type - Global Opportunity Analysis and Industry Forecast, ... is expected to reach $4,531 million by 2022, registering a CAGR of 6.42% ... for more than one-third share of the global volume in 2015. ... ...
(Date:1/16/2017)... 16, 2017  Dovetail Genomics today announced the commercial ... service, which yields chromosome-scale genome assemblies. The service is ... workshop on Jan. 17 at the Plant & Animal ... . "We are thrilled to be ... our Dovetail Hi-C offering," said Todd Dickinson , ...
Breaking Medicine Technology:
(Date:1/16/2017)... GA (PRWEB) , ... January 16, 2017 , ... ... to announce their recent partnership with an innovator in the wheelchair accessibility industry, ... to motivate their dealer salespeople to sell wheelchair accessible vehicles. With this new ...
(Date:1/16/2017)... ... ... One thing common to all types of cancer is that it’s a ... money spent screening for and treating cancer in the United States is estimated to ... than in any other country that has an advanced healthcare system, sometimes spending as ...
(Date:1/15/2017)... ... January 15, 2017 , ... Going above and ... that strives to better communities around the world by offering the Gensuite team ... the opportunity for team members to become involved in a cause that is ...
(Date:1/15/2017)... ... 14, 2017 , ... Wondering where to go this Valentine's Day? Well, there ... for a romantic, lobster feast in the comfort of your own home. Lobster Gram ... dinners will be featured until February 15th, 2017. , Romantic Dinner one is ...
(Date:1/14/2017)... ... January 14, 2017 , ... AgileMinder develops innovative products and services ... Scale is now available on Apple as a fun, free emoji sticker pack for ... one of the ten color coded values on The Emoji Scale. , On ...
Breaking Medicine News(10 mins):